KERX Financial Facts
Net loss: -41.7MInterest and other income, net: 150K
See Full Income Statement
Total current assets: 159.95M
Additional paid-in capital: 823.55M
See Full Balance Sheet
Keryx Biopharmaceuticals Inc. (KERX) Earnings
|
Expand Research on KERX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -97.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/7/18 |  |
Q417 | -$0.26 | -$0.18 | -$0.08 | $18.7M | $17.53M | = |  | | Details |
| 11/7/17 | |
Q317 | -$0.20 | -$0.18 | -$0.02 | $15M | $18.04M | = | | | Details |
| 7/27/17 | Q217 | -$0.77 | -$0.18 | -$0.59 | $15.1M | $14.51M | = | | | Details | |
| 5/4/17 | |
Q117 | -$0.21 | -$0.20 | -$0.01 | $11.8M | $10.27M | = | | | Details |
| 3/1/17 | |
Q416 | -$0.32 | -$0.25 | -$0.07 | $9.5M | $8.41M | = | | | Details |
11/9/16  |
|
Q316 | -$0.39 | -$0.20 | -$0.19 | $6.3M | $5.37M | N/A | | | Details |
| 8/1/16 | Q216 | -$0.42 | -$0.28 | -$0.14 | $9.3M | $8.6M | N/A | | | Details | |
| 4/28/16 |
|
Q116 | -$0.39 | -$0.26 | -$0.13 | $6.8M | $6.63M | N/A | | | Details |
